Talking Precision Medicine
Talking Precision Medicine
Genialis
The Science and Art of De-risking Cancer Drug Development | Talking Precision Medicine #35
31 minutes Posted Apr 12, 2024 at 8:19 am.
0:00
31:27
Download MP3
Show notes

In this episode Genialis CEO Rafael Rosengarten sat down with Dr. Carolina Haefliger, head of translational medicine at Debiopharm, the privately held Swiss biopharma company focused on oncology drug development. They talked about de-risking promising new cancer drugs, and what it takes from the science to the team to the technologies.

Episode 35 links: